# "Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer

> **NCT03072992** · PHASE2 · COMPLETED · sponsor: **National Center of Oncology, Armenia** · enrollment: 150 (actual)

## Conditions studied

- Advanced Breast Cancer
- Metastatic Breast Cancer

## Interventions

- **DRUG:** Curcumin
- **DRUG:** Paclitaxel
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03072992
- **Lead sponsor:** National Center of Oncology, Armenia
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-20
- **Primary completion:** 2018-11-20
- **Final completion:** 2019-06-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2019-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03072992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03072992, ""Curcumin" in Combination With Chemotherapy in Advanced Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03072992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*